The results revealed a significant increase in ERCC1 expression in 20 cancers, including GBMLGG, BRCA, HNSC, etc. Further, a significant decrease in ERCC1 expression was shown in patients with CESC, LUAD, OV, and TGCT (Figure 2A). Here, ERCC1 is linked to cancer.